Newsflash

Newsflash: Oxytocin can take the heat, more strage flexibility with TTI: PATH's HealthTech program recently presented data showing that the time temperature exposure indicators (TTIs) used with almost all vaccines purchased by the United Nations Children’s Fund may also be used with oxytocin.

Uniting Africans to Save Women's Lives from Postpartum Hemorrhage: Historic gathering to address world's highest rate of maternal mortality. JHPIEGO News Release

This news brief speaks to the urget need to address the high maternal mortality rate in Africa and describes the ACCESS program which is a leading effort worldwide to reduce maternal mortality through a combination of approaches. The news brief also introduces a groundbreaking conference that was organized by the ACCESS Program in partnership with the Regional Centre for Quality of Health Care (RCQHC), the East, Central, and Southern Africa Health Secretariat (ECSA), and POPPHI.

View web page

A Report of an Evaluation of Training Strategies for the Management of Third Stage of Labor

This report summarizes an evaluation conducted by POPPHI on training strategies for the management of third stage of labor, outlines relevant resources, and presents preliminary recommendations based on evaluation findings. An appendix includes a list of technical and training resources including, web links, training documents, and other relevant resources used in the evaluation.

Download/view (312 KB PDF)

WHO Recommendations for the Prevention of Postpartum Haemorrhage

This document describes the technical consultation process, evaluates the evidence using the GRADE methodology, and provides the full set of recommendations from the World Health Organization (WHO) Technical Consultation on the Prevention of Postpartum Haemorrhage held in Geneva October 18 to 20, 2006. It makes recommendations to continue WHO's support for AMTSL, identifies who can provide AMTSL, and gives support to the use of misoprostol for prevention of postpartum hemorrhage, based on the evidence.

Download/view (1495 KB PDF)

Saving women’s lives: evidence-based recommendations for the prevention of postpartum haemorrhage

This document reports on the WHO Technical Consultation on Prevention of PPH held from October 18 to 20, 2006 and gives recommendations from WHO on how to prevent postpartum hemorrhage. In addition to the recommendation that all skilled birth attendants (SBAs) should provide active management of the third stage of labor (AMTSL), it was also recommended that a uterotonic (either oxytocin or misoprostol) can be used alone to prevent postpartum hemorrhage, when there is not a trained SBA to provide AMTSL. The full Technical Consultation recommendations include that the uterotonic can be provided by a trained health worker (it does not state skilled birth attendant).

Download/view (93 KB PDF)

Global Survey on the Management of the Third Stage of Labor Reports

These studies aim to provide ministries of health and their partners with data about the actual practice of AMTSL, including policy, provider-support, and supplies and logistics, along with the descriptive information necessary to assess AMTSL practices and identify barriers to its use in their country.

Facility-based Management of the Third Stage of Labor and Community Perceptions and Actions on Postpartum Hemorrhage Findings from a National Survey in Ethiopia: (734 KB PDF)

Facility-based Management of the Third Stage of Labor and Community Perceptions and Actions on Postpartum Hemorrhage Findings from a National Survey in Tanzania: (742 KB PDF)

MPS Technical Update: Prevention of Postpartum Haemorrhage by Active Management of Third Stage of Labour (October 2006)

This WHO document outlines WHO's recommendation that active management of the third stage of labor be offered by all skilled attendants at every birth, giving the background, evidence, and steps for the intervention.

Download/view (245 KB PDF)

Misoprostol for Prevention of Postpartum Hemorrhage: An Evidence-based Review by the United States Pharmacopeia (USP)

This report provides the evidence tables behind the USP recommendation that prevention of postpartum hemorrhage be included as an indication in the USP Drug Information monograph on misoprostol.

Download/view (605 KB PDF)

Misoprostol for Prevention of Postpartum Hemorrhage: An Evidence-Based Review by U.S. Pharmacopeia (USP)

This poster summarizes the USP review of the evidence and conclusions on the use of misoprostol for the prevention of postpartum hemorrhage.

Download/view (687 KB PDF)

Directions in Global Health December 2006 issue

This PATH publication highlights POPPHI's work on preventing postpartum hemorrhage.

Download/view (450 KB PDF)

Essential Medicines for Reproductive Health: Guiding Principles for Inclusion on National Medicines Lists

This publication from WHO, the United Nations Population Fund, and PATH provides information on the process for including reproductive health medicines on national essential medicines lists at the country level based on the essential medicines concept. Injectable oxytocin is described on pages 102 to 104 of the document.

Download/view (487 KB PDF)

Use of uterotonic drugs for prevention and treatment of postpartum hemorrhage in tropical climates: Guidance for essential drug and safe motherhood programs

This draft document is being shared with the Prevention of Postpartum Hemorrhage email list for comment. If you would like to subscribe to the listserv, please visit the Postpartum Hemorrhage email list website and follow the instructions.

Download/view (217 KB PDF)

Stability of injectable oxytocics in tropical climates Results of field surveys and simulation studies on ergometrine, methylergometrine and oxytocin

This WHO publication presents information on the stability of uterotonic drugs for active management of the third stage of labor in tropical climates.

Download/view (1,281 KB PDF)

Active Management of the Third Stage of Labor: A Simple Practice to Prevent Postpartum Hemorrhage

This Global Health Technical Brief presents information on postpartum hemorrhage and active management of the third stage of labor.

View web page

Preventing Postpartum Hemorrhage: Managing the Third Stage of Labor

This issue of Outlook, PATH's quarterly reproductive health newsletter, reviews preventing postpartum hemorrhage through active management of the third stage of labor.

English version (75 KB PDF)

Versión español (123 KB PDF)

Version française (66 KB PDF)

Indonesian version (562 KB PDF)

Misoprostol Use in Obsetrics and Gynecology

This issue of Outlook, PATH's quarterly reproductive health newsletter, provides evidence-based information on the emerging use of misoprostol in obstetrics and gynecology.

English version (562 KB PDF)

Versión español (182 KB PDF)

First Aid for Women and Newborns Where Home Birth is Necessary or Common

This Global Health Technical Brief presents information on the Home Based Life Saving Skills program.

View web page

Managing Complications in Pregnancy and Childbirth A guide for midwives and doctors

This World Health Organization manual offers important information on complications including postpartum hemorrhage.

English version

Version française

Versión español

Misoprostol and Postpartum Hemorrhage (PPH) Research, April 2007, Version 7

This document, compiled by POPPHI, provides information of studies on the use of misoprostol in the prevention and treatment of postpartum hemorrhage, as of April 2007.

Download/view (PDF 63KB)